About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

CellSource Co., Ltd.(4880) Summary

4880
TSE Prime
CellSource Co., Ltd.
651
JPY
+37
(+6.03%)
Apr 18, 3:30 pm JST
4.57
USD
Apr 18, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
50.5
PBR
2.20
Yield
0.77%
Margin Trading Ratio
27.13
Stock Price
Apr 18, 2025
Opening Apr 18, 9:00 am
618 JPY 4.34 USD
Previous Close Apr 17
614 JPY 4.29 USD
High Apr 18, 11:23 am
653 JPY 4.58 USD
Low Apr 18, 9:02 am
616 JPY 4.32 USD
Volume
56,300
Trading Value
0.04B JPY 0.25M USD
VWAP
642.39 JPY 4.51 USD
Minimum Trading Value
65,100 JPY 457 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
288
Liquidity & Number of Trades
As of Apr 18, 2025
Liquidity
Mid
1-Year Average
362
1-Year High Jul 17, 2024
2,256
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 11, 2025 0 325,800
Apr 4, 2025 0 380,300
Mar 28, 2025 0 369,900
Mar 21, 2025 0 356,700
Mar 14, 2025 0 360,000
Company Profile
CellSource Co., Ltd. develops and sells regenerative medicine-related products and cosmetics, specializing in cell processing from fat and blood.
Sector
Pharmaceuticals
CellSource Co., Ltd. primarily focuses on regenerative medicine-related businesses, providing cell processing and storage services from blood and fat for medical institutions. The company operates facilities licensed for manufacturing specific cell products under the Act on the Safety of Regenerative Medicine, where they extract, culture, and cryopreserve adipose-derived stem cells. Additionally, CellSource offers consulting services for regulatory compliance and management support necessary for providing regenerative medicine, as well as sales of related medical equipment. Furthermore, the company manufactures and sells its own cosmetics brand "Signalift," which incorporates proprietary ingredients derived from adipose stem cell research. CellSource also supplies cosmetic raw materials and provides OEM manufacturing services.